Table 2.
DF group (n: 20) |
D group (n: 35) |
P-value | |
---|---|---|---|
Recipient data | |||
Age (years), mean ± SE | 59.6 ± 2.2 | 61.4 ± 1.8 | 0.54 |
Male, n (%) | 9 (45) | 24 (68.6) | 0.09 |
BMI (kg/m2), mean ± SE | 26.3 ± 1.2 | 27 ± 0.8 | 0.63 |
Race, n (%) | |||
Afro-American | 2 (10) | 6 (17.1) | 0.47 |
Hispanic | 14 (70) | 17 (48.6) | 0.12 |
Caucasian | 4 (20) | 12 (34.3) | 0.26 |
MELD score, mean ± SE | 27.7 ± 1.4 | 29.2 ± 1.1 | 0.41 |
DM, n (%) | 10 (50) | 26 (74.3) | 0.07 |
ESRD etiology, n (%) | |||
HRS | 5 (25) | 17 (48.6) | 0.09 |
Metabolic (DM and/or HTN) | 7 (35) | 22 (62.9) | 0.05 |
PKD | 5 (25) | 2 (5.7) | 0.04 |
Glomerulonephritis | 2 (10) | 1 (2.9) | 0.26 |
Othera | 4 (20) | 9 (25.7) | 0.63 |
Timing of kidney failure, n (%) | |||
AKI | 3 (15) | 6 (17.1) | 0.84 |
AKI on CKI | 2 (10) | 11 (31.4) | 0.07 |
CKI | 15 (75) | 18 (51.4) | 0.09 |
Dialysis modality | |||
Pre-emptive, n (%) | 5 (25) | 9 (25.7) | 0.95 |
Hemodialysis, n (%) | 15 (75) | 26 (74.3) | 0.95 |
Pre-transplant CVVH, n (%) | 4 (20) | 5 (14.3) | 0.58 |
Liver re-transplant, n (%) | 0 (0) | 5 (14.3) | 0.08 |
Kidney re-transplant, n (%) | 0 (0) | 1 (2.9) | 0.45 |
Serum Albumin (g/dL), mean*/SE | 3.69*/1.05 | 3.05*/1.04 | 0.006 |
Platelet count (per ml), mean*/SE | 79.6*/1.2 | 55.7*/1.1 | 0.14 |
INR value, mean*/SE | 1.36*/1.07 | 1.64*/1.06 | 0.04 |
Donor data | |||
Age (years), mean ± SE | 36.4 ± 3.5 | 40.2 ± 2.4 | 0.36 |
BMI (kg/m2), mean ± SE | 25.5 ± 1.1 | 25.5 ± 0.8 | 0.99 |
DCD, n (%) | 4 (20) | 6 (17.1) | 0.79 |
KDPI (%), mean ± SE | 41.6 ± 5.7 | 42.2 ± 3.9 | 0.93 |
Kidney transplant data | |||
Delayed KTx, n (%) | 14 (35) | 26 (65) | 0.73 |
CIT (h), mean ± SE | 18.5 ± 2.2 | 27.3 ± 2.2 | 0.01 |
WIT (min), mean ± SE | 28.1 ± 1.6 | 30.8 ± 1.3 | 0.21 |
Placement of ureteral stent, n (%) | 0 (0) | 4 (11.4) | 0.12 |
Calcineurin Inhibitor Toxicity, Focal Segmental Glomerulosclerosis, HCV or HIV nephropathy.
BMI, Body Mass Index; MELD, Model for End-stage Liver Disease; DM, Diabetes Mellitus; ESRD, End-Stage Renal Disease; HRS, Hepato-Renal Syndrome; HTN, Hypertension; PKD, Polycystic Kidney Disease; AKI, Acute Kidney Injury; CKI, Chronic Kidney Injury; CVVH, Continuous Venous-Venous Hemofiltration; DCD, Donation after Cardiac Death; KDPI, Kidney Donor Profile Index; CIT, Cold Ischemic Time; WIT, Warm Ischemic Time.